» Authors » Charis Marwick

Charis Marwick

Explore the profile of Charis Marwick including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 345
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang H, Casey A, Guellil I, Suarez-Paniagua V, MacRae C, Marwick C, et al.
Front Digit Health . 2023 Dec; 5:1186208. PMID: 38090654
Introduction: Linking free-text addresses to unique identifiers in a structural address database [the Ordnance Survey unique property reference number (UPRN) in the United Kingdom (UK)] is a necessary step for...
2.
MacBride-Stewart S, Marwick C, Ryan M, Guthrie B
Br J Gen Pract . 2022 Jul; PMID: 35817581
Background: Potentially inappropriate prescribing (PIP) of asthma bronchodilator inhalers is associated with increased morbidity and mortality. Aim: To evaluate the effectiveness of feedback on the PIP of bronchodilator inhalers. Design...
3.
MacRae C, Henderson D, Mercer S, Burton J, De Souza N, Grill P, et al.
BJGP Open . 2021 Oct; 5(6). PMID: 34620596
Background: Care home residents often have multiple cognitive and physical impairments, and are at high risk of adverse drug events (ADEs). Aim: To describe excessive polypharmacy and potentially inappropriate prescribing...
4.
Grill P, Marwick C, De Souza N, Burton J, Hughes C, Guthrie B
Age Ageing . 2020 Jul; 50(1):183-189. PMID: 32706851
Background: older people living in care-homes are particularly vulnerable to adverse effects of psychotropic and anticholinergic drugs. Methods: anonymised dispensed prescription data from all 4,478 residents aged ≥ 60 years...
5.
Shah A, McAllister D, Gallacher P, Astengo F, Perez J, Hall J, et al.
Circulation . 2020 May; 141(25):2067-2077. PMID: 32410460
Background: Despite improvements in management, infective endocarditis remains associated with high mortality and morbidity. We describe temporal changes in the incidence, microbiology, and outcomes of infective endocarditis and the effect...
6.
Malcolm W, Fletcher E, Kavanagh K, Deshpande A, Wiuff C, Marwick C, et al.
J Antimicrob Chemother . 2017 Oct; 73(1):223-230. PMID: 29040608
Background: Urinary tract infections (UTIs) are common. Antibiotic treatment is usually empirical, with the risk of under-treatment of resistant infections. Objectives: To characterize risk factors for antibiotic-resistant community urine isolates...
7.
MacBride-Stewart S, Marwick C, Houston N, Watt I, Patton A, Guthrie B
Br J Gen Pract . 2017 Mar; 67(658):e352-e360. PMID: 28347986
Background: It is uncertain whether improvements in primary care high-risk prescribing seen in research trials can be realised in the real-world setting. Aim: To evaluate the impact of a 1-year...
8.
Kavanagh K, Pan J, Marwick C, Davey P, Wiuff C, Bryson S, et al.
J Antimicrob Chemother . 2016 Dec; 72(4):1193-1201. PMID: 27999064
Background: Community-associated Clostridium difficile infection (CA-CDI; defined as cases without prior hospitalization in the previous 12 weeks who were either tested outside of hospital or tested within 2 days of...
9.
Walker H, Patton A, Bayne G, Marwick C, Sneddon J, Davey P, et al.
J Antimicrob Chemother . 2016 May; 71(9):2598-605. PMID: 27231276
Objectives: Evidence has shown that a prophylactic antibiotic regimen of flucloxacillin and gentamicin for orthopaedic surgery was associated with increased rates of post-operative acute kidney injury (AKI). This resulted in...
10.
Bonnici-Mallia M, Kanodia A, Rae N, Marwick C
BMJ Case Rep . 2016 Apr; 2016. PMID: 27056942
No abstract available.